Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone antibiotic presented as an oral dosage form for systemic use. It is employed to treat infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients. It is also indicated for community‑acquired and hospital‑acquired pneumonia and for skin and soft‑tissue infections.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates the pathogen and resolves the infection. - Vancomycin‑resistant Enterococcus (VRE) infections: eliminates resistant strains and restores clinical improvement. - Community‑acquired and hospital‑acquired pneumonia: clears pulmonary infection and improves respiratory function. - Skin and soft‑tissue infections: reduces bacterial load and promotes wound healing.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: persistent metallic sensation in the mouth. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: risk when combined with serotonergic agents. - Myelosuppression: bone‑marrow suppression affecting blood cells. - Lactic acidosis: accumulation of lactate causing metabolic disturbance. - Optic neuropathy: visual disturbances due to optic nerve involvement.

Before prescribing Linezolid, consider patient‑specific factors and monitor appropriately. - Renal impairment: adjust therapy and monitor renal function. - Hepatic impairment: use with caution and assess liver enzymes. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Hematologic monitoring: regularly check complete blood counts for cytopenias. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Linezolid can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: increase risk of serotonin syndrome. - Tyramine‑rich foods: can cause severe hypertension when combined.

Moderate Interactions (Monitor Closely): - Rifampin: reduces linezolid plasma concentrations. - Antacids containing aluminum or magnesium: may decrease absorption. - Warfarin: potential alteration of INR, requiring coagulation monitoring.